Intrinsic Value of S&P & Nasdaq Contact Us

ABVC BioPharma, Inc. ABVC NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
42/100
2/7 Pass
SharesGrow Intrinsic Value
$15.87
+1066.9%

Stock Statistics — ABVC

ABVC BioPharma, Inc. (ABVC) has a market capitalization of $19.71M and trades at $1.36. The 52-week range is 0.735-5.48.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.5, Earnings Per Share (EPS) of $-0.39, annual revenue of $795.95K.

The stock has a beta of 0.38, operates in the Healthcare sector.

Trading Data
Current Price$1.36
52-Week Range0.735-5.48
Volume128.72K
Avg Volume (30D)81.94K
Market Cap$19.71M
Beta (1Y)0.38
Company
IPO Date2004-11-10
Employees16
CEOUttam Yashwant Patil
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS00091F3047
CUSIP00091F106
Income (Latest Year)
Revenue$795.95K
Gross Profit$795.95K
EBITDA$-6.65M
Operating Income$-7.15M
Net Income$-7.91M
EPS$-0.39
EPS Diluted$-0.39
Shares Outstanding$23.26M
Balance Sheet (Latest Year)
Total Assets$21.06M
Current Assets$2.5M
Cash & ST Investments$745.83K
Total Liabilities$7.76M
Total Debt$3.47M
Net Debt$2.79M
Total Equity$13.3M
Debt / Equity0.26
Valuation Ratios
P/E Ratio-3.5
P/S Ratio24.76
P/B Ratio1.48
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message